Cellular Senescence Requires CDK5 Repression of Rac1 Activity

REFERENCES

• Alexander, K., and Hinds P. W.. 2001. Requirement for p27KIP1 in retinoblastoma protein-mediated senescence. Mol. Cell. Biol. 21:3616–3631.
   PubMedGoogle Scholar
• Banerjee, M., Worth D., Prowse D. M., and Nikolic M.. 2002. Pak1 phosphorylation on t212 affects microtubules in cells undergoing mitosis. Curr. Biol. 12:1233–1239.
   PubMedGoogle Scholar
• Bodnar, A. G., Ouellette M., Frolkis M., Holt S. E., Chiu C. P., Morin G. B., Harley C. B., Shay J. W., Lichtsteiner S., and Wright W. E.. 1998. Extension of life-span by introduction of telomerase into normal human cells. Science 279:349–352.
   PubMed Web of Science ®Google Scholar
• Bringold, F., and Serrano M.. 2000. Tumor suppressors and oncogenes in cellular senescence. Exp. Gerontol. 35:317–329.
   PubMed Web of Science ®Google Scholar
• Brookes, S., Rowe J., Ruas M., Llanos S., Clark P. A., Lomax M., James M. C., Vatcheva R., Bates S., Vousden K. H., Parry D., Gruis N., Smit N., Bergman W., and Peters G.. 2002. INK4a-deficient human diploid fibroblasts are resistant to RAS-induced senescence. EMBO J. 21:2936–2945.
   PubMed Web of Science ®Google Scholar
• Campisi, J. 1996. Replicative senescence: an old lives' tale? Cell 84:497–500.
   PubMed Web of Science ®Google Scholar
• Chou, M. M., and Blenis J.. 1996. The 70 kDa S6 kinase complexes with and is activated by the Rho family G proteins Cdc42 and Rac1. Cell 85:573–583.
   PubMedGoogle Scholar
• Collado, M., Medema R., Garcia-Cao I., Dubuisson M., Barradas M., Glassford J., Rivas C., Burgering B., Serrano M., and Lam E.. 2000. Inhibition of the phosphoinositide 3-kinase pathway induces a senescence-like arrest mediated by p27Kip1. J. Biol. Chem. 275:21960–21968.
   PubMedGoogle Scholar
• Dai, C., and Enders G.. 2000. p16 INK4a can initiate an autonomous senescence program. Oncogene 19:1613–1622.
   PubMed Web of Science ®Google Scholar
• Dickson, M. A., Hahn W. C., Ino Y., Ronfard V., Wu J. Y., Weinberg R. A., Louis D. N., Li F. P., and Rheinwald J. G.. 2000. Human keratinocytes that express hTERT and also bypass a p16INK4a-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol. Cell. Biol. 20:1436–1447.
   PubMed Web of Science ®Google Scholar
• Dimri, G. P., Itahana K., Acosta M., and Campisi J.. 2000. Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14ARF tumor suppressor. Mol. Cell. Biol. 20:273–285.
   PubMed Web of Science ®Google Scholar
• Dimri, G. P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., Medrano E. E., Linskens M., Rubelj I., Pereira-Smith O., et al. 1995. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA 92:9363–9367.
   PubMed Web of Science ®Google Scholar
• Dulic, V., Beney G., Frebourg G., Drullinger L., and Stein G.. 2000. Uncoupling between phenotypic senescence and cell cycle arrest in aging p21-deficient fibroblasts. Mol. Cell. Biol 20:6741–6754.
   PubMedGoogle Scholar
• Hall, A. 1998. Rho GTPases and the actin cytoskeleton. Science 279:509–514.
   PubMed Web of Science ®Google Scholar
• He, T. C., Zhou S., da Costa L. T., Yu J., Kinzler K. W., and Vogelstein B.. 1998. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA 95:2509–2514.
   PubMed Web of Science ®Google Scholar
• Hinds, P. W., Mittnacht S., Dulic V., Arnold A., Reed S. I., and Weinberg R. A.. 1992. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70:993–1006.
   PubMed Web of Science ®Google Scholar
• Hsueh, Y. P., Kim E., and Sheng M.. 1997. Disulfide-linked head-to-head multimerization in the mechanism of ion channel clustering by PSD-95. Neuron 18:803–814.
   PubMedGoogle Scholar
• Kissil, J. L., Wilker E. W., Johnson K. C., Eckman M. S., Yaffe M. B., and Jacks T.. 2003. Merlin, the product of the Nf2 tumor suppressor gene, is an inhibitor of the p21-activated kinase, Pak1. Mol. Cell 12:841–849.
   PubMed Web of Science ®Google Scholar
• Kiyono, T., Foster S. A., Koop J. I., McDougall J. K., Galloway D. A., and Klingelhutz A. J.. 1998. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396:84–88.
   PubMed Web of Science ®Google Scholar
• Kolquist, K. A., Ellisen L. W., Counter C. M., Meyerson M., Tan L. K., Weinberg R. A., Haber D. A., and Gerald W. L.. 1998. Expression of TERT in early premalignant lesions and a subset of cells in normal tissues. Nat. Genet. 19:182–186.
   PubMed Web of Science ®Google Scholar
• Lin, A. W., Barradas M., Stone J. C., van Aelst L., Serrano M., and Lowe S. W.. 1998. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev. 12:3008–3019.
   PubMed Web of Science ®Google Scholar
• Lundberg, A., Hahn W., Gupta P., and Weinberg R.. 2000. Genes involved in senescence and immortalization. Curr. Opin. Cell Biol. 12:705–709.
   PubMed Web of Science ®Google Scholar
• MacCioni, R. B. 2001. Cdk5. Eur. J. Biochem. 268:1517.
   PubMedGoogle Scholar
• Meijer, L., Borgne A., Mulner O., Chong J. P., Blow J. J., Inagaki N., Inagaki M., Delcros J. G., and Moulinoux J. P.. 1997. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur. J. Biochem. 243:527–536.
   PubMedGoogle Scholar
• Meyerson, M., Counter C. M., Eaton E. N., Ellisen L. W., Steiner P., Caddle S. D., Ziaugra L., Beijersbergen R. L., Davidoff M. J., Liu Q., Bacchetti S., Haber D. A., and Weinberg R. A.. 1997. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90:785–795.
   PubMed Web of Science ®Google Scholar
• Mittnacht, S., and Weinberg R. A.. 1991. G1/S phosphorylation of the retinoblastoma protein is associated with an altered affinity for the nuclear compartment. Cell 65:381–393.
   PubMed Web of Science ®Google Scholar
• Nikolic, M., Chou M. M., Lu W., Mayer B. J., and Tsai L. H.. 1998. The p35/Cdk5 kinase is a neuron-specific Rac effector that inhibits Pak1 activity. Nature 395:194–198.
   PubMed Web of Science ®Google Scholar
• Nobes, C. D., and Hall A.. 1995. Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 81:53–62.
   PubMed Web of Science ®Google Scholar
• Olson, M. F., Ashworth A., and Hall A.. 1995. An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1. Science 269:1270–1272.
   PubMed Web of Science ®Google Scholar
• Opitz, O. G., Suliman Y., Hahn W. C., Harada H., Blum H. E., and Rustgi A. K.. 2001. Cyclin D1 overexpression and p53 inactivation immortalize primary oral keratinocytes by a telomerase-independent mechanism. J. Clin. Investig. 108:725–732.
   PubMed Web of Science ®Google Scholar
• Philpott, A., Porro E. B., Kirschner M. W., and Tsai L. H.. 1997. The role of cyclin-dependent kinase 5 and a novel regulatory subunit in regulating muscle differentiation and patterning. Genes Dev. 11:1409–1421.
   PubMed Web of Science ®Google Scholar
• Rashid, T., Banerjee M., and Nikolic M.. 2001. Phosphorylation of Pak1 by the p35/Cdk5 kinase affects neuronal morphology. J. Biol. Chem. 276:49043–49052.
   PubMed Web of Science ®Google Scholar
• Ren, X. D., and Schwartz M. A.. 2000. Determination of GTP loading on Rho. Methods Enzymol. 325:264–272.
   PubMed Web of Science ®Google Scholar
• Rheinwald, J. G., Hahn W. C., Ramsey M. R., Wu J. Y., Guo Z., Tsao H., De Luca M., Catricala C., and O'Toole K. M.. 2002. A two-stage, p16INK4A- and p53-dependent keratinocyte senescence mechanism that limits replicative potential independent of telomere status. Mol. Cell. Biol. 22:5157–5172.
   PubMed Web of Science ®Google Scholar
• Ridley, A. J. 1999. Rho family proteins and regulation of the actin cytoskeleton. Prog. Mol. Subcell. Biol. 22:1–22.
   PubMedGoogle Scholar
• Sahai, E., and Marshall C. J.. 2002. RHO-GTPases and cancer. Nat. Rev. Cancer 2:133–142.
   PubMed Web of Science ®Google Scholar
• Schmitt, C. A., Fridman J. S., Yang M., Lee S., Baranov E., Hoffman R. M., and Lowe S. W.. 2002. A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell 109:335–346.
   PubMed Web of Science ®Google Scholar
• Serrano, M., Lin A. W., McCurrach M. E., Beach D., and Lowe S. W.. 1997. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88:593–602.
   PubMed Web of Science ®Google Scholar
• Sui, G., Soohoo C., Affar E. B., Gay F., Shi Y., Forrester W. C., and Shi Y.. 2002. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc. Natl. Acad. Sci. USA 99:5515–5520.
   PubMed Web of Science ®Google Scholar
• Templeton, D. J., Park S. H., Lanier L., and Weinberg R. A.. 1991. Nonfunctional mutants of the retinoblastoma protein are characterized by defects in phosphorylation, viral oncoprotein association, and nuclear tethering. Proc. Natl. Acad. Sci. USA 88:3033–3037.
   PubMed Web of Science ®Google Scholar
• Tiemann, F., and Hinds P. W.. 1998. Induction of DNA synthesis and apoptosis by regulated inactivation of a temperature-sensitive retinoblastoma protein. EMBO J. 17:1040–1052.
   PubMedGoogle Scholar
• Tiemann, F., Musunuru K., and Hinds P. W.. 1997. In Swallow D. M. and Edwards Y. (ed.), Protein dysfunction in human genetic diseases, p. 163–185. BIOS Scientific Publishers, Oxford, United Kingdom.
   Google Scholar
• Xu, H. J., Zhou Y., Ji W., Perng G. S., Kruzelock R., Kong C. T., Bast R. C., Mills G. B., Li J., and Hu S. X.. 1997. Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibition. Oncogene 15:2589–2596.
   PubMedGoogle Scholar
• Yamamoto, M., Marui N., Sakai T., Morii N., Kozaki S., Ikai K., Imamura S., and Narumiya S.. 1993. ADP-ribosylation of the rhoA gene product by botulinum C3 exoenzyme causes Swiss 3T3 cells to accumulate in the G1 phase of the cell cycle. Oncogene 8:1449–1455.
   PubMed Web of Science ®Google Scholar
• Yang, H. S., and Hinds P. W.. 2003. Increased Ezrin expression and activation by CDK5 coincident with acquisition of the senescent phenotype. Mol. Cell 11:1163–1176.
   PubMedGoogle Scholar
• Zhong, J. L., Banerjee M. D., and Nikolic M.. 2003. Pak1 and its T212 phosphorylated form accumulate in neurones and epithelial cells of the developing rodent. Dev. Dyn. 228:121–127.
   PubMedGoogle Scholar
• Zhu, J., Woods D., McMahon M., and Bishop J. M.. 1998. Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev. 12:2997–3007.
   PubMed Web of Science ®Google Scholar